Capsule Summary Slides

Share

Program Content

Activities

  • FLAIR SC Substudy
    FLAIR SC Substudy: LA CAB + RPV by Abdominal Subcutaneous Injection
    Conference Coverage
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: July 25, 2024

    Expires: July 24, 2025

  • IMPAACT 2017 Cohort 2 Week 48 Results
    IMPAACT 2017/MOCHA Cohort 2: Wk 48 Safety, Efficacy, and PK Data After Switching to LA CAB + RPV in Adolescents Living With HIV
    Conference Coverage
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: July 25, 2024

    Expires: July 24, 2025

  • LEN PrEP
    PURPOSE-1: Phase III Trial of Twice-Yearly LEN vs Daily FTC/TAF or FTC/TDF for HIV PrEP in Cisgender Women
    Conference Coverage
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: July 26, 2024

    Expires: July 25, 2025

  • ARTISTRY-1
    ARTISTRY-1: Wk 48 Data After Switch From Complex ART to Bictegravir + Lenacapavir in Virologically Suppressed People With HIV
    Conference Coverage
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: July 26, 2024

    Expires: July 25, 2025

  • DTG/3TC in People With HIV and Anti HBc
    GEMINI-1/-2, STAT, TANGO, SALSA: Safety and Efficacy of DTG/3TC in Persons With HIV and Isolated Anti-HBc
    Conference Coverage
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: July 26, 2024

    Expires: July 25, 2025

  • REPRIEVE MACE Incidence
    REPRIEVE: Higher Incidence of MACE Observed With Current and Former Use of ABC
    Conference Coverage
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: July 26, 2024

    Expires: July 25, 2025

  • SOLAR 3D  Wk 144 Results
    SOLAR-3D: Wk 144 Results of Switching to DTG/3TC in Virologically Suppressed Heavily Treatment–Experienced People With HIV
    Conference Coverage
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: July 26, 2024

    Expires: July 25, 2025

  • D2EFT
    D2EFT: Final Outcomes Analysis of Second-line DRV-/DTG-Based ART After First-line NNRTI Failure
    Conference Coverage
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: July 26, 2024

    Expires: July 25, 2025

  • PASO DOBLE (GeSIDA 11720 ): DTG/3TC vs BIC/TAF/FTC
    PASO-DOBLE (GeSIDA 11720): Switch to DTG/3TC vs BIC/TAF/FTC in Virologically Suppressed Persons With HIV
    Conference Coverage
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: July 28, 2024

    Expires: July 27, 2025

  • VISEND 144 Week Results
    VISEND: Wk 144 Results of Switch From NNRTI-Based ART to PI-Based ART vs DTG + Recycled NRTIs
    Conference Coverage
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: July 29, 2024

    Expires: July 28, 2025

Faculty

cover img faculity

Angela Davies, MD

Assistant Professor of Medicine
UC Davis Cancer Center
Sacramento, CA

PT Faculty

cover img faculity

CCO and PCE staff

cover img faculity

Kishan J. Pandya, MD, FACP

Professor Emeritus of Medicine and Oncology
James P. Wilmont Cancer Center
University of Rochester Medical Center   
Rochester, New York

cover img faculity

Janine Trevillyan, MD

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC.

Supporters

Supported by educational grants from Gilead Sciences, Inc. and ViiV Healthcare.

Gilead Sciences, Inc.

ViiV Healthcare

Partners

IAS

ProCE Banner

Produced in partnership with the International AIDS Society.